Spatial Domains
Dominant neighborhood compartment and purity from Tier 1 domain summaries. Bulk files are centralized on the Download page.
151-200 of 2,070
Spatial Domains
Dominant neighborhood compartment and purity from Tier 1 domain summaries.
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B2,1 | Lung | Primary cancer | 2,353 | Tumor/Malignant | 65.2% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__175_B2,10 | Lung | Primary cancer | 2,177 | Tumor/Malignant | 41.4% | 0.90 | 0.34 |
| NSCLC_38242124__IMC__175_B2,11 | Lung | Primary cancer | 3,015 | Tumor/Malignant | 44.2% | 0.89 | 0.35 |
| NSCLC_38242124__IMC__175_B2,12 | Lung | Primary cancer | 2,539 | Tumor/Malignant | 30.7% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__175_B2,13 | Lung | Primary cancer | 3,504 | Tumor/Malignant | 46.9% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__175_B2,14 | Lung | Primary cancer | 2,748 | Tumor/Malignant | 87.7% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__175_B2,15 | Lung | Primary cancer | 3,020 | Tumor/Malignant | 31.2% | 0.86 | 0.40 |
| NSCLC_38242124__IMC__175_B2,16 | Lung | Primary cancer | 3,084 | Tumor/Malignant | 41.6% | 0.48 | 0.92 |
| NSCLC_38242124__IMC__175_B2,17 | Lung | Primary cancer | 2,285 | Stromal | 38.6% | 0.76 | 0.60 |
| NSCLC_38242124__IMC__175_B2,2 | Lung | Primary cancer | 1,910 | Tumor/Malignant | 50.1% | 0.90 | 0.33 |
| NSCLC_38242124__IMC__175_B2,3 | Lung | Primary cancer | 4,979 | Tumor/Malignant | 74.8% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__175_B2,4 | Lung | Primary cancer | 3,269 | Tumor/Malignant | 54.1% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__175_B2,5 | Lung | Primary cancer | 3,929 | Tumor/Malignant | 83.0% | 0.98 | 0.05 |
| NSCLC_38242124__IMC__175_B2,6 | Lung | Primary cancer | 3,446 | Tumor/Malignant | 40.9% | 0.93 | 0.33 |
| NSCLC_38242124__IMC__175_B2,7 | Lung | Primary cancer | 3,595 | Tumor/Malignant | 97.5% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__175_B2,8 | Lung | Primary cancer | 2,386 | Tumor/Malignant | 34.3% | 0.89 | 0.39 |
| NSCLC_38242124__IMC__175_B2,9 | Lung | Primary cancer | 4,016 | Tumor/Malignant | 44.6% | 0.99 | 0.09 |
| NSCLC_38242124__IMC__175_B3,1 | Lung | Primary cancer | 3,874 | Tumor/Malignant | 60.6% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B3,10 | Lung | Primary cancer | 1,896 | Stromal | 28.0% | 0.51 | 0.85 |
| NSCLC_38242124__IMC__175_B3,11 | Lung | Primary cancer | 2,889 | Tumor/Malignant | 73.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B3,12 | Lung | Primary cancer | 4,330 | Tumor/Malignant | 61.4% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__175_B3,13 | Lung | Primary cancer | 912 | Stromal | 35.3% | 0.87 | 0.39 |
| NSCLC_38242124__IMC__175_B3,15 | Lung | Primary cancer | 2,727 | Stromal | 41.4% | 0.46 | 0.83 |
| NSCLC_38242124__IMC__175_B3,16 | Lung | Primary cancer | 4,456 | Stromal | 25.5% | 0.56 | 0.79 |
| NSCLC_38242124__IMC__175_B3,17 | Lung | Primary cancer | 2,318 | Tumor/Malignant | 40.3% | 0.90 | 0.31 |
| NSCLC_38242124__IMC__175_B3,2 | Lung | Primary cancer | 3,084 | Tumor/Malignant | 29.8% | 0.37 | 0.98 |
| NSCLC_38242124__IMC__175_B3,3 | Lung | Primary cancer | 4,329 | Tumor/Malignant | 80.9% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__175_B3,4 | Lung | Primary cancer | 1,576 | Tumor/Malignant | 48.8% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B3,5 | Lung | Primary cancer | 3,081 | Tumor/Malignant | 67.9% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__175_B3,6 | Lung | Primary cancer | 3,664 | Tumor/Malignant | 34.4% | 0.88 | 0.35 |
| NSCLC_38242124__IMC__175_B3,7 | Lung | Primary cancer | 2,763 | Tumor/Malignant | 28.3% | 0.86 | 0.46 |
| NSCLC_38242124__IMC__175_B3,8 | Lung | Primary cancer | 4,496 | Tumor/Malignant | 47.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B3,9 | Lung | Primary cancer | 3,044 | Tumor/Malignant | 79.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B4,1 | Lung | Primary cancer | 3,046 | Tumor/Malignant | 51.1% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__175_B4,10 | Lung | Primary cancer | 1,320 | Tumor/Malignant | 27.2% | 0.75 | 0.66 |
| NSCLC_38242124__IMC__175_B4,11 | Lung | Primary cancer | 2,898 | Tumor/Malignant | 85.2% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__175_B4,12 | Lung | Primary cancer | 4,536 | Tumor/Malignant | 95.6% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__175_B4,13 | Lung | Primary cancer | 2,834 | Tumor/Malignant | 52.2% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B4,14 | Lung | Primary cancer | 3,599 | Tumor/Malignant | 42.5% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__175_B4,15 | Lung | Primary cancer | 3,084 | Tumor/Malignant | 38.8% | 0.55 | 0.74 |
| NSCLC_38242124__IMC__175_B4,16 | Lung | Primary cancer | 4,218 | Tumor/Malignant | 32.7% | 0.51 | 0.73 |
| NSCLC_38242124__IMC__175_B4,17 | Lung | Primary cancer | 3,092 | Tumor/Malignant | 37.2% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B4,2 | Lung | Primary cancer | 2,911 | Tumor/Malignant | 44.2% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__175_B4,3 | Lung | Primary cancer | 3,892 | Tumor/Malignant | 54.8% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__175_B4,4 | Lung | Primary cancer | 2,855 | Tumor/Malignant | 38.1% | 0.86 | 0.36 |
| NSCLC_38242124__IMC__175_B4,5 | Lung | Primary cancer | 3,190 | Tumor/Malignant | 49.8% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__175_B4,6 | Lung | Primary cancer | 3,026 | Tumor/Malignant | 48.2% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__175_B4,7 | Lung | Primary cancer | 2,360 | Tumor/Malignant | 57.8% | 0.91 | 0.29 |
| NSCLC_38242124__IMC__175_B4,8 | Lung | Primary cancer | 5,430 | Tumor/Malignant | 66.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__175_B4,9 | Lung | Primary cancer | 3,378 | Tumor/Malignant | 88.0% | 1.00 | 0.02 |